跳至主要内容
临床试验/CTRI/2024/01/061873
CTRI/2024/01/061873尚未招募4 期

Efficacy of laser activated 3% hydrogen peroxide and 2% povidone iodine as an adjunct to non-surgical periodontal therapy in stage II periodontitis patients - a randomized clinical trial

Dr Akriti Mishra1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年2月9日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
10
试验地点
1
主要终点
Periodontal probing depth (PD)

研究概览

简要总结

This study is designed as a randomised controlled, single-blind, single centre trialto compare the antimicrobial effect of nonsurgical periodontal therapy with SRP alone, laser activation along with SRP, photoactivation of 2% povidone iodine with 940nm diode laser in combination with SRP and photoactivation of 3% hydrogen peroxide with 940 nm diode laser in combination with SRP.

The markers will be evaluated at baseline (before treatment), one month after treatment and 3 months after treatment.

  • Periodontal probing depth (PD)
  • Bleeding on probing (BOP)
  • Clinical attachment level (CAL)

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • systemically healthy male or female between 18-60 years age
  • at least 20 natural teeth present in the oral cavity distributed in 4 quadrants
  • each quadrant containing at least two teeth with periodontal pocket depth (PPD) of less than or equal to 5 mm and clinical attachment loss (CAL) of 2 mm or greater
  • bleeding on probing (BOP) in all 4 quadrants.

排除标准

  • patients who are during active periodontal treatment or have had undergone periodontal treatment within 12 months
  • patients who have had antibiotic therapy (systemic or local) over the past 6 months
  • systemic conditions that may affect the therapeutic outcome (diabetes type 1 and 2, immune deficiency, hepatitis B virus, hepatitis C virus, cancer, hematological disorders, epilepsy, etc.)
  • pregnancy, breastfeeding
  • incapacity or refusal to follow the study protocol
  • severe comorbid conditions that may affect life expectancy within 1 year (e.g., metastatic cancer)
  • allergy to iodine.

结局指标

主要结局

Periodontal probing depth (PD)

时间窗: The markers will be evaluated at baseline (before treatment) and 3 months after treatment.

Bleeding on probing (BOP)

时间窗: The markers will be evaluated at baseline (before treatment) and 3 months after treatment.

Clinical attachment level (CAL)

时间窗: The markers will be evaluated at baseline (before treatment) and 3 months after treatment.

次要结局

  • Periodontal probing depth (PD)(Bleeding on probing (BOP))

研究者

发起方
Dr Akriti Mishra
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Akriti Mishra

AB Shetty Memorial Institute of Dental Sciences

研究点 (1)

Loading locations...

相似试验